Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial

Marco Ladetto, Katja Gutmair, Rita Tavarozzi, Alexandra Pawlikowski, Michael Schomaker, Jeanette Doorduijn, Eva Giné, Mats Jerkeman, Jan Walewski, Martin Hutchings, Ulrich Mey, Jon Riise, Marek Trneny, Vibeke K.J. Vergote, Netanel A. Horowitz, Maria Gomes da Silva, Sirpa Leppä, Linmiao Jiang, Stephan Stilgenbauer, Andrea Kerkhoff, Ron D. Jachimowicz, Georg Heß, Tom van Meerten, Stefan Wirths, Peter Herhaus, Urban Novak, Judith Dierlamm, Mathias Hänel, Christine Hanoun, Kristina Sonnevi, Carlo Visco, Claudia Castellino, Roberto Massimo Lemoli, Vittorio Ruggero Zilioli, Carola Boccomini, Christiane Pott, Wolfram Klapper, Christian Schmidt, Martin Dreyling, Eva Hoster, Unknown

Open source

DOI
10.1200/jco-26-00705
Published
2026-09-20
Container
Journal of Clinical Oncology
Publisher
American Society of Clinical Oncology (ASCO)
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco-26-00705,
  title = {Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial},
  author = {Marco Ladetto and Katja Gutmair and Rita Tavarozzi and Alexandra Pawlikowski and Michael Schomaker and Jeanette Doorduijn and Eva Giné and Mats Jerkeman and Jan Walewski and Martin Hutchings and Ulrich Mey and Jon Riise and Marek Trneny and Vibeke K.J. Vergote and Netanel A. Horowitz and Maria Gomes da Silva and Sirpa Leppä and Linmiao Jiang and Stephan Stilgenbauer and Andrea Kerkhoff and Ron D. Jachimowicz and Georg Heß and Tom van Meerten and Stefan Wirths and Peter Herhaus and Urban Novak and Judith Dierlamm and Mathias Hänel and Christine Hanoun and Kristina Sonnevi and Carlo Visco and Claudia Castellino and Roberto Massimo Lemoli and Vittorio Ruggero Zilioli and Carola Boccomini and Christiane Pott and Wolfram Klapper and Christian Schmidt and Martin Dreyling and Eva Hoster and Unknown},
  year = {2026},
  journal = {Journal of Clinical Oncology},
  doi = {10.1200/jco-26-00705},
  url = {https://doi.org/10.1200/jco-26-00705}
}

RIS

TY  - JOUR
TI  - Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial
AU  - Marco Ladetto
AU  - Katja Gutmair
AU  - Rita Tavarozzi
AU  - Alexandra Pawlikowski
AU  - Michael Schomaker
AU  - Jeanette Doorduijn
AU  - Eva Giné
AU  - Mats Jerkeman
AU  - Jan Walewski
AU  - Martin Hutchings
AU  - Ulrich Mey
AU  - Jon Riise
AU  - Marek Trneny
AU  - Vibeke K.J. Vergote
AU  - Netanel A. Horowitz
AU  - Maria Gomes da Silva
AU  - Sirpa Leppä
AU  - Linmiao Jiang
AU  - Stephan Stilgenbauer
AU  - Andrea Kerkhoff
AU  - Ron D. Jachimowicz
AU  - Georg Heß
AU  - Tom van Meerten
AU  - Stefan Wirths
AU  - Peter Herhaus
AU  - Urban Novak
AU  - Judith Dierlamm
AU  - Mathias Hänel
AU  - Christine Hanoun
AU  - Kristina Sonnevi
AU  - Carlo Visco
AU  - Claudia Castellino
AU  - Roberto Massimo Lemoli
AU  - Vittorio Ruggero Zilioli
AU  - Carola Boccomini
AU  - Christiane Pott
AU  - Wolfram Klapper
AU  - Christian Schmidt
AU  - Martin Dreyling
AU  - Eva Hoster
AU  - Unknown
PY  - 2026
JO  - Journal of Clinical Oncology
DO  - 10.1200/jco-26-00705
UR  - https://doi.org/10.1200/jco-26-00705
ER  - 

APA

Ladetto, M., Gutmair, K., Tavarozzi, R., Pawlikowski, A., Schomaker, M., Doorduijn, J., Giné, E., Jerkeman, M., Walewski, J., Hutchings, M., Mey, U., Riise, J., Trneny, M., Vergote, V. K., Horowitz, N. A., Silva, M. G. D., Leppä, S., Jiang, L., Stilgenbauer, S., Kerkhoff, A., Jachimowicz, R. D., Heß, G., Meerten, T. V., Wirths, S., Herhaus, P., Novak, U., Dierlamm, J., Hänel, M., Hanoun, C., Sonnevi, K., Visco, C., Castellino, C., Lemoli, R. M., Zilioli, V. R., Boccomini, C., Pott, C., Klapper, W., Schmidt, C., Dreyling, M., Hoster, E., & Unknown (2026). Rituximab Maintenance Added to Ibrutinib-Containing Therapy in Younger, Untreated Patients With Mantle Cell Lymphoma: Results From the TRIANGLE Trial. Journal of Clinical Oncology. https://doi.org/10.1200/jco-26-00705

Source records